Medical Marijuana Research Act of 2017

norml logo-min

mj_research-minRepresentatives Andy Harris, M.D. (R-MD-01), Earl Blumenauer (D-OR-03), H. Morgan Griffith (R-VA-09), and Zoe Lofgren (D-CA-19) introduced H.R. 3391: The Medical Marijuana Research Act of 2017.

This Act amends the federal law to facilitate clinical investigations involving the use of cannabis and cannabis-derived products.

As you may know, there are many benefits to medical cannabis. Those suffering from PTSD, Tourette’s Syndrome, Parkinson’s Disease, and many other debilitating conditions have found relief because of medical marijuana.

But, despite the fact that over 200 million Americans now have legal access to some form of medical marijuana, present regulations make clinical investigations involving cannabis needlessly onerous. Passage of this measure would expedite federal reviews of clinical protocols, provide greater access to scientists who wish to study the drug, and mandate an FDA review of the relevant science.

Please click HERE to contact your Representative and urge him/her to support this important measure.


Connect To Your Customers & Grow Your Business

Click Here

Print Friendly

Be the first to comment on "Medical Marijuana Research Act of 2017"

Leave a comment

Your email address will not be published.


*